Why Genomic Tests for Prostate Cancer Need Better Data
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Category: Prostate
Prostate
Latest
Prostate
Latest
Prostate Cancer Risks for Transgender Women on Hormone Therapy
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Prostate
Latest
Oncobiomix Adopts AI-Based Disease Insights Platform for Prostate Cancer Test
Oncobiomix says it will use Limmi's Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Black Men are More Likely to Have Prostate Cancer than White Men
Black men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.Â
Read More
ArteraAI Validates Prognostic Model in Advanced Prostate Cancer
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read More
New Algorithm Predicts Prostate Cancer Recurrence for Radiation Therapy Patients
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.Â
Read More
Precision Medicine Navigators Increase Genomic Testing Rates for Black Patients with Prostate Cancer
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read More
Detecting Metastatic Prostate Cancer Risk in Black Men
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read More
Researcher Leads Development of Urine Test for Prostate Cancer Detection
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read More
How Veracyte’s Prostate Genomic Classifier Guides Cancer Treatment
A new study demonstrated Decipher Prostate Genomic Classifier’s ability to guide personalized treatment for men with prostate cancer.Â
Read More
Quest Launches Prostate Cancer Test to Improve Diagnosis and Grading
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.Â
Read More
AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read More
Cleveland Diagnostics’ New Facility will Feature IsoPSAÂ Testing
Cleveland Diagnostics, a biotechnology company developing next-gen diagnostic tests for early detection of cancers, opened a new facility.
Read More
American Indian, Alaska Native Men Less Likely to Get Prostate Cancer Screening
American Indian and Alaska Native men also experience disproportionately greater prostate cancer mortality compared to other racial/ethnic identities.
Read More
Personalizing Prostate Cancer Screening May Improve Detection Accuracy
The accuracy of PSA in prostate cancer screening can be improved by accounting for genetic factors that are not associated with cancer.
Read More
‘Test by Request’ PSA Testing Drive Cancer Overdiagnosis
Experts argue that “test by request” have led to higher PSA testing and clear medical harm, with minimal benefit and inequity.
Read More
Randox Introduces PSA Test for Indications of Prostate Cancer
Levels of PSA are low in healthy men but elevate in the presence of prostate cancer and other mentioned conditions.Â
Read More
New Prostate Cancer Biopsy Procedure Improves Accuracy
A new minimally invasive prostate biopsy procedure reduces the risk of infection, improves imaging for accuracy, and may increase cancer detection in a clinic setting.
Read More